DuPont Falls After Keeping Forecast Unchanged: Wilmington Mover

DuPont Co. (DD), the most valuable U.S. chemicals producer, fell after disappointing investors who expected the company to raise its 2012 profit forecast after posting higher-than-expected first-quarter earnings.

Dupont dropped as much as 2.2 percent, the biggest intraday decline since Feb. 14, before closing 1.2 percent lower at $52.61 in New York.

Net income rose to $1.57 a share in the three months through March, from $1.52 a year earlier, Wilmington, Delaware- based DuPont said today in a statement. Profit excluding costs related to damage caused by the herbicide Imprelis was $1.61, topping the $1.53 average of 13 analysts’ estimates compiled by Bloomberg.

A warmer-than-normal spring boosted U.S. and European sales of pesticides and genetically modified seeds, bringing forward to the first quarter 3 cents a share in earnings that would typically occur in the second quarter, Jim Borel, executive vice president of DuPont’s agriculture unit, said on a conference call.

The decision not to raise full-year guidance “might prove disappointing to some investors in light of the strong first- quarter results as it could imply that some of the strength reflected a pull forward of Ag earnings due to the early start to the U.S. planting season,” Don Carson, a New York-based analyst at Susquehanna Financial, said today in a report.

DuPont reiterated its January forecast that adjusted earnings will climb to $4.20 to $4.40 a share this year, from $3.93 in 2011. That compares with the $4.27 average estimate of 17 analysts surveyed by Bloomberg.

DuPont also said first-quarter net sales gained 12 percent to $11.2 billion from $10 billion, matching the average of 12 estimates. The company raised prices for its products by 8 percent on average in the period. Sales volumes fell 2 percent, led by declines in the electronics unit and in the Asia Pacific region.

To contact the reporters on this story: Jack Kaskey in Houston at; Jef Feeley in Wilmington, Delaware at

To contact the editor responsible for this story: Simon Casey at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.